Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers.


Journal

Journal of diabetes science and technology
ISSN: 1932-2968
Titre abrégé: J Diabetes Sci Technol
Pays: United States
ID NLM: 101306166

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 14 3 2019
medline: 10 9 2020
entrez: 14 3 2019
Statut: ppublish

Résumé

Benefits of telemedicine have been proven in the field of diabetes. Among a number of technical solutions, Diabeo® has been studied in both type 1 and type 2 diabetes with intensive insulin therapy. This digital therapeutic system contains a self-monitoring glucose logbook and offers automated insulin dose recommendations thanks to a fully customizable algorithm. In addition, the cloud-based dedicated software also has features to facilitate remote monitoring, including a platform for diabetes nurses who perform coaching and treatment adjustment. A detailed description of this telemedicine system is provided, as well as results of completed clinical studies. In particular, TeleDiab 1's positive results on HbA1c in type 1 diabetes are detailed. We conclude with a discussion of the role of this telemedicine system within the landscape of mobile apps for diabetes.

Identifiants

pubmed: 30862245
doi: 10.1177/1932296819834054
pmc: PMC6835183
doi:

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1161-1168

Références

Diabetes Care. 2011 Sep;34(9):1934-42
pubmed: 21788632
JMIR Res Protoc. 2018 Apr 19;7(4):e66
pubmed: 29674306
BMC Med. 2015 May 06;13:106
pubmed: 25943590
Diabetes Res Clin Pract. 2016 Nov;121:17-26
pubmed: 27616634
Telemed J E Health. 2015 May;21(5):321-54
pubmed: 25806910
J Diabetes Sci Technol. 2016 Jun 28;10(4):977-80
pubmed: 26798082
Front Pharmacol. 2017 May 30;8:330
pubmed: 28611672
Diabetes Care. 2015 Jun;38(6):971-8
pubmed: 25998289
Endocrinol Metab Clin North Am. 2016 Dec;45(4):943-965
pubmed: 27823614
Sci Rep. 2017 Oct 4;7(1):12680
pubmed: 28978949
Diabetes Care. 2011 Mar;34(3):533-9
pubmed: 21266648
Diabetes Metab. 2014 Feb;40(1):61-6
pubmed: 24139705
NPJ Digit Med. 2018 May 9;1:12
pubmed: 31304297

Auteurs

Michael Joubert (M)

Diabetes Care Unit, Caen University Hospital, Caen, France.

Pierre-Yves Benhamou (PY)

Department of Diabetology, Pôle DigiDune, University Hospital, Grenoble, France.

Pauline Schaepelynck (P)

Department of Nutrition-Endocrinology-Metabolic Disorders, Marseille University Hospital, Sainte Marguerite Hospital, Marseille, France.

Hélène Hanaire (H)

Department of Diabetology, Metabolic Diseases and Nutrition, CHU Toulouse, University of Toulouse, Toulouse, France.

Bogdan Catargi (B)

Department of Endocrinology and Diabetes, University Hospital, Bordeaux, France.

Anne Farret (A)

Department of Endocrinology, Diabetes and Nutrition, University Hospital, Montpellier, France.

Pierre Fontaine (P)

Department of Diabetology, University Hospital, Lille, France.

Bruno Guerci (B)

Endocrinology-Diabetes Care Unit, University of Lorraine, Vandoeuvre Lès Nancy, France.

Yves Reznik (Y)

Diabetes Care Unit, Caen University Hospital, Caen, France.

Nathalie Jeandidier (N)

Department of Endocrinology, Diabetes and Nutrition. CHU of Strasbourg, Strasbourg, France.

Alfred Penfornis (A)

University Paris-Sud, Orsay, Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France.

Sophie Borot (S)

Centre Hospitalier Universitaire Jean Minjoz, Service d'Endocrinologie-Métabolisme et Diabétologie-Nutrition, Besançon, France.

Lucy Chaillous (L)

Department of Endocrinology, Diabetology and Nutrition, Institut du Thorax, Nantes University Hospital, France.

Sylvia Franc (S)

CERITD (Centre d'étude et de Recherche pour l'Intensification du Traitement du Diabète), Evry, Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France.

Pierre Serusclat (P)

Endocrinology, Diabetology and Nutrition, Clinique Portes du Sud, Venissieux, France.

Yacine Kherbachi (Y)

Sanofi-Diabetes, Gentilly, France.

Eric Bavière (E)

Voluntis, Suresnes, France.

Bruno Detournay (B)

CEMKA-EVAL, Bourg-la-Reine, France.

Pierre Simon (P)

National Association of Telemedicine, Paris, France.

Guillaume Charpentier (G)

CERITD (Centre d'étude et de Recherche pour l'Intensification du Traitement du Diabète), Evry, Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH